# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-21-000119
Filing Date
2021-08-03
Accepted
2021-08-02 19:56:13
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20210630.htm iXBRL | 10-Q | 1622650
2 | EX-31.1 | lgnd_63021exhibit311.htm | EX-31.1 | 15166
3 | EX-31.2 | lgnd_63021exhibit312.htm | EX-31.2 | 15399
4 | EX-32.1 | lgnd_63021exhibit321.htm | EX-32.1 | 11345
10 |  | lgnd-20210630_g1.jpg | GRAPHIC | 51754
| Complete submission text file | 0000886163-21-000119.txt |  | 8119744

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20210630.xsd | EX-101.SCH | 47379
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20210630_cal.xml | EX-101.CAL | 91029
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20210630_def.xml | EX-101.DEF | 294320
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20210630_lab.xml | EX-101.LAB | 700585
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20210630_pre.xml | EX-101.PRE | 428967
11 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20210630_htm.xml | XML | 1476203

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 211137452
SIC: 2834 Pharmaceutical Preparations